International Congress of Parkinson's Disease & Movement Disorders
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Congress of Parkinson's Disease & Movement Disorders — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
International Congress of Parkinson’s Disease & Movement Disorders (MDS Congress) — 2026
The International Congress of Parkinson’s Disease and Movement Disorders is a global scientific meeting dedicated to advancing research, clinical practice, and cross-disciplinary collaboration in Parkinson’s disease and related movement disorders. The 2026 edition will take place in Seoul, Korea at the COEX Convention and Exhibition Center, located at 513, Yeongdong-daero, Gangnam-gu, Seoul 06164, Korea, from October 4–8, 2026.
Event overview
This congress brings together clinicians, researchers, healthcare professionals, and industry partners to explore the latest advancements across the field. The scientific program is designed to support knowledge-sharing at both the high level (major expert discussions and emerging research) and the practical level (real-world cases and hands-on learning opportunities). The 2026 program features 60+ timely scientific sessions, including hands-on skill workshops, real patient and case presentations, and sessions that address both cutting-edge technologies and controversial or rapidly evolving topics.
Key program features
- 60+ scientific sessions spanning emerging research areas and current debates in Parkinson’s disease and movement disorders.
- Live patient and case-based sessions to support practical clinical understanding and decision-making.
- Hands-on skill workshops focused on skills and learning relevant to patient care and clinical practice.
- Innovation showcases highlighting novel and significant research developments.
- MDS Talks and Networking Events designed to foster professional connections throughout the meeting.
- Video Challenge as an additional forum for presenting and engaging with innovative ideas and content.
Collaboration and organization
The congress is presented in collaboration with the Korean Movement Disorder Society (KMDS). The event is organized by the MDS International Secretariat.
Location and venue
Venue: COEX Convention and Exhibition Center
Address: 513, Yeongdong-daero, Gangnam-gu, Seoul 06164, Korea
Dates: October 4–8, 2026
Additional updates mentioned on the official site
- The congress includes live session translations and provides real-time AI captions in 60+ languages.
- Late-breaking scientific content is supported through an abstract submission process.
Overall, the International Congress of Parkinson’s Disease and Movement Disorders is positioned as a high-impact, international meeting focused on meaningful clinical relevance and research momentum, bringing together the global movement-disorders community in Seoul for five days of scientific exchange, practical learning, and professional networking.
Data sheet
International Congress of Parkinson's Disease & Movement Disorders – Event Attendee & Buyer Profile Analysis
Event Date: October 4–8, 2026 | Location: Seoul, South Korea | Event Status: Upcoming | Research Date: July 1, 2026
Event Overview
| Field | Details |
|---|---|
| Event Name | International Congress of Parkinson's Disease and Movement Disorders® |
| Event Date | October 4–8, 2026 |
| Event Status | Upcoming |
| Venue | COEX Convention and Exhibition Center |
| City | Seoul |
| State / Region | Seoul Capital Area |
| Country | South Korea |
| Organizer | MDS International Secretariat / International Parkinson and Movement Disorder Society |
| Official Event Website | mdscongress.org |
| Event Type | International medical congress, scientific conference, clinical education and industry exhibition platform |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium. Official date, venue, city, and program intent are confirmed; current-year attendance totals are not publicly posted in the provided source text. |
| Main Purpose of Event | To convene clinicians, researchers, industry partners, and allied professionals focused on Parkinson’s disease and movement disorders for education, research exchange, clinical advancement, and networking. |
About the Event
| The International Congress of Parkinson's Disease and Movement Disorders® is a flagship global scientific meeting dedicated to Parkinson’s disease, movement disorders, and related neurological research and clinical practice. The official 2026 edition is scheduled for Seoul, South Korea, at COEX Convention and Exhibition Center, and features a multi-day congress format with scientific sessions, abstract presentations, late-breaking research, clinical breakthroughs, networking, and industry participation. |
| This congress matters because it brings together a highly specialized audience with direct influence on diagnosis, treatment pathways, clinical adoption, research collaboration, and product evaluation. It is especially relevant for pharmaceutical firms, biotech innovators, medtech developers, clinical research organizations, hospital systems, academic medical centers, digital health vendors, and suppliers supporting neurology, neurorehabilitation, diagnostics, and patient care. The event is also well suited for B2B attendee list building due to its concentration of decision-makers, specialists, and commercially relevant stakeholders. |
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Movement disorder specialists / neurologists | Hospitals, academic medical centers, specialty neurology clinics | Clinical decision-makers, protocol influencers, product evaluators | High-value targets for therapies, diagnostics, monitoring tools, software, and research partnerships. |
| Academic researchers / neuroscientists | Universities, research institutes, teaching hospitals | Research collaborators, trial investigators, publication leaders | Relevant for trial recruitment, research tools, data platforms, biomarker solutions, and grant-supported collaborations. |
| Clinical trial and R&D leaders | Pharma, biotech, CROs, academic trial centers | Protocol design, study feasibility, site selection | Strong fit for clinical research services, patient recruitment, eClinical software, and trial operations support. |
| Pharma and biotech medical affairs | Drug developers, specialty pharma, therapeutic manufacturers | Evidence generation, KOL engagement, congress strategy | Important for speakers, symposium sponsors, investigator networks, and market access education. |
| Hospital administrators / service line leaders | Hospitals, neurology centers, integrated health systems | Budget authority, care model adoption, service purchasing | Relevant for clinical equipment, digital workflow tools, remote monitoring, and patient management solutions. |
| Therapy and rehabilitation leaders | Rehab hospitals, outpatient therapy groups, multidisciplinary clinics | Program selection, treatment pathway implementation | Targets for mobility, assistive technology, rehabilitation platforms, and patient engagement products. |
| Digital health / health IT leaders | Healthcare technology vendors, hospital IT teams, digital therapeutics firms | Technology adoption, integration, vendor selection | Relevance for AI, monitoring, tele-neurology, data capture, and workflow solutions. |
| Regulatory / market access / HEOR teams | Life sciences companies, consulting firms, payer-focused organizations | Evidence strategy, reimbursement and access planning | Relevant for real-world evidence, outcomes research, and value communication services. |
| Association leaders / opinion leaders | Medical societies, advocacy organizations, guideline bodies | Program influence, partnership development, education leadership | Useful for sponsorships, educational grants, and collaboration-based outreach. |
| Industry media / publishers | Medical publishers, journals, news outlets | Content amplification and visibility | Useful for thought leadership, product launches, and event publicity. |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Seoul | Strong local participation from hospitals, universities, and life sciences firms in the Seoul metropolitan area | High | Seoul is a major medical, academic, and corporate hub, supporting strong local and regional turnout. |
| Host region: Seoul Capital Area | Greater Seoul, Incheon, Gyeonggi-do | High | Dense concentration of academic hospitals, research institutions, and commercial healthcare organizations. |
| National reach: South Korea | Nationwide clinical and research participants | High | Specialist audience likely to include neurology departments from major hospitals across South Korea. |
| Asia-Pacific | Japan, China, Taiwan, Singapore, Hong Kong, Australia, India, Southeast Asia | Medium to High | Regional scientific relevance and proximity support broad Asia-Pacific attendance. |
| Global | Europe, North America, Latin America, Middle East | Medium | International congress branding and specialty focus attract global experts, sponsors, and researchers. |
| Nearby business hubs | Pharma, medtech, CRO, and health technology firms operating in regional clusters | Medium | Opportunity for multinational commercial teams to meet KOLs and research collaborators in one location. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The congress serves an international specialty community with cross-border clinical, academic, and industry participation. |
| Secondary reach | Asia-Pacific stronghold | Seoul location increases access to Asia-Pacific specialists and life sciences organizations while maintaining global appeal. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| International Parkinson and Movement Disorder Society (MDS) | Association / organizer | Congress owner and core audience hub for education, sponsorship, and professional networking. | movementdisorders.org | Executive Director, Education Director, Congress Director, Partnerships Director | Confirmed Government / Procurement Organization |
| The Korean Movement Disorder Society (KMDS) | Association / co-collaborator | Local collaboration partner with access to Korean clinician and researcher networks. | kmds.or.kr | President, Secretariat Lead, Scientific Committee Chair, Partnerships Lead | Confirmed Speaker Organization |
| Severance Hospital | Hospital / academic medical center | Major neurology and movement disorder care center; likely fit for clinical solutions and research engagement. | severance.healthcare | Head of Neurology, Clinical Research Director, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Samsung Medical Center | Hospital / academic medical center | Large tertiary care institution with strong neurology and research capability. | samsungmedicalcenter.com | Neurology Chair, Research Office Director, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Asan Medical Center | Hospital / academic medical center | Key Korean hospital system relevant for advanced neurology care, trials, and medical technology adoption. | amc.seoul.kr | Department Head, Trial Operations Manager, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health, Korea | Government health / research | Public-sector research and clinical evidence stakeholder for neurological disease programs. | nih.go.kr | Research Director, Program Manager, Public Health Officer | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharma | Potential sponsor and medical affairs target for neurology-related scientific engagement. | pfizer.com | Medical Affairs Director, Clinical Development Lead, Brand Lead | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharma | Therapeutic and medical affairs relevance for neuroscience and specialty treatment areas. | abbvie.com | Medical Science Liaison Lead, VP Medical Affairs, Market Access Director | Strong Market Fit, Attendance Not Confirmed |
| UCB | Biopharma | Neurology-focused global biopharma with high strategic fit for congress engagement. | ucb.com | Neurology BU Head, Regional Medical Director, KOL Engagement Lead | Strong Market Fit, Attendance Not Confirmed |
| Boehringer Ingelheim | Pharma | Relevant for neuroscience R&D, medical education, and clinical partnership activity. | boehringer-ingelheim.com | Clinical Trial Lead, Medical Affairs Manager, Alliance Director | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharma / diagnostics | Relevant where diagnostics, biomarkers, and clinical research intersect with movement disorders. | roche.com | Diagnostics Lead, Clinical Strategy Director, Scientific Affairs Manager | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical devices | Deep relevance in neuromodulation and device-based therapy for movement disorders. | medtronic.com | Product Manager, Clinical Affairs Director, Regional Sales Director | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / VP Medical Affairs | Medical Affairs | VP / C-Level | Drives scientific engagement, congress strategy, and evidence-based partnership decisions. |
| 2 | Director of Clinical Development | Clinical Development | Director | Influences study design, investigator relationships, and trial site engagement. |
| 3 | Head of Neurology / Department Chair | Clinical / Academic | Director / Senior | Shapes treatment pathways, research collaboration, and technology adoption. |
| 4 | Clinical Research Director | R&D / Research | Director | Relevant for trials, biomarker studies, registries, and investigator-led research. |
| 5 | Medical Science Liaison | Medical Affairs | Manager / Senior | Central to KOL mapping, scientific exchange, and educational outreach. |
| 6 | Product Manager | Product / Marketing | Manager | Evaluates market needs, product fit, and launch messaging for neurology solutions. |
| 7 | Procurement Manager | Procurement | Manager | Purchasing authority for devices, software, services, and hospital solutions. |
| 8 | Operations Director | Operations | Director | Influences workflow, service delivery, and technology implementation. |
| 9 | Digital Health Lead / Health IT Director | IT / Innovation | Director | Evaluates remote monitoring, telehealth, analytics, and workflow tools. |
| 10 | Trial Operations Manager | Clinical Operations | Manager | Coordinates study execution, site operations, and vendor selection. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Primary commercial audience for neuroscience therapies, medical education, and evidence generation. | Medical affairs, clinical development, brand teams, and market access outreach. |
| 2 | Biotechnology | Important for translational research, biomarker development, and neurology pipeline companies. | Research partnerships, investigator engagement, and early-stage trial support. |
| 3 | Medical Devices | Relevant to neuromodulation, monitoring, diagnostics, and clinical equipment adoption. | Product launches, clinical evaluation, and hospital purchasing conversations. |
| 4 | Hospital & Health Care | Core buyer base for clinical practice, patient pathways, and care delivery innovation. | Hospital decision-makers, neurology departments, and service line leaders. |
| 5 | Research | Congress is highly research-intensive and centered on scientific exchange. | Principal investigators, lab leaders, and academic collaboration outreach. |
| 6 | Medical Practice | Specialist clinicians and private practice neurologists may attend for continuing education. | Clinician-targeted tools, diagnostics, and education programs. |
| 7 | Information Technology & Services | Digital health, AI, remote monitoring, and data integration are increasingly relevant. | Health IT, analytics, and clinical workflow software vendors. |
| 8 | Internet | Digital patient engagement and telehealth platforms intersect with care delivery. | Virtual care, patient portal, and digital engagement solutions. |
| 9 | Management Consulting | Strategy and commercialization advisors serve life sciences and healthcare clients. | Partnerships, market research, and commercialization services. |
| 10 | Logistics & Supply Chain | Relevant for pharma supply, medical device distribution, and hospital procurement support. | Distribution, cold chain, and procurement optimization services. |
| 11 | Government Administration | Public hospitals, national research programs, and health agencies may participate. | Public-sector health programs and procurement engagement. |
| 12 | Education Management | Academic and continuing medical education institutions are important stakeholder groups. | CME, training, congress education, and academic partnerships. |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official 2026 event text provided | No organizer-published attendee figure in the supplied official content. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | Official 2026 event text provided | Industry sponsor/exhibit area is referenced, but count not published in the provided source text. |
| Buyer count | Not publicly confirmed | Confirmed unavailable | Official 2026 event text provided | Buyer-side composition must be inferred from congress scope rather than a published count. |
| Speaker count | Not publicly confirmed | Confirmed unavailable | Official 2026 event text provided | The website confirms 60+ scientific sessions, but not a total speaker count. |
| Sponsor count | Not publicly confirmed | Confirmed unavailable | Official 2026 event text provided | Sponsor / exhibit participation is referenced in navigation, but no count is provided. |
| Historical attendance | Use prior-year verification if needed | Historical / prior-year evidence | Official congress archives may be used if accessed separately | Current-year attendance figure not publicly confirmed by the organizer. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical research | Trial design, recruitment, site activation, evidence generation | Connect with investigators and sponsor teams seeking research support | CRO services, research platforms, patient recruitment |
| Therapeutics | Disease management, treatment innovation, medical education | Engage medical affairs and KOL networks | Pharma, biotech, specialty therapeutic programs |
| Diagnostics / biomarkers | Earlier detection, patient stratification, outcome tracking | Meet clinicians and R&D teams focused on precision medicine | Diagnostics, assays, biomarker analytics |
| Digital health | Remote monitoring, telemedicine, adherence, real-world data | Target hospital IT and innovation teams | Software, dashboards, mobile health tools |
| Neuromodulation / devices | Advanced treatment options and device adoption | Reach clinical decision-makers evaluating procedure-based solutions | Medical devices, implantable technologies, accessories |
| Education / CME | Specialist training and continuing education | Connect with societies, faculty, and academic departments | CME platforms, learning systems, content services |
| Market access / HEOR | Clinical and economic evidence for adoption | Engage reimbursement and value teams | HEOR consulting, evidence generation, payer strategy |
| Patient engagement | Adherence, education, symptom tracking | Demonstrate patient-centric tools to care teams | Apps, portals, education content, support programs |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event concentrates clinical, research, and industry buyers directly relevant to neurology and movement disorders. |
| Decision-maker availability | High | Likely presence of department heads, clinicians, medical affairs, research leaders, and commercial stakeholders. |
| Data collection potential | High | Congress attendee intelligence, session themes, faculty lists, and industry pages can support targeted outreach. |
| Apollo targeting potential | Very High | Strong fit for Apollo filtering by pharma, biotech, hospitals, research, medtech, and healthcare IT. |
| Geographic targeting potential | High | Seoul location supports precise targeting of Korea, APAC, and global medical accounts. |
| Best outreach approach | High | Use educational, scientific, and partnership-led messaging rather than generic sales outreach. |
| Overall lead quality | Very High | Specialty congress with strong concentration of qualified, high-value B2B and clinical stakeholders. |
| Best use case | Very High | Conference lead generation, attendee list building, sponsor prospecting, KOL mapping, and account-based marketing. |
| Limitations / risks | Medium | Public attendance counts and participant lists are not fully disclosed in the provided official text. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Hospital & Health Care; Research; Medical Practice; Information Technology & Services; Government Administration; Education Management; Management Consulting | Capture the full buyer and influencer ecosystem around the congress. |
| Departments | Medical Affairs; Clinical Development; Research; Operations; Procurement; Product; IT; Innovation; Business Development; Marketing | Reach both clinical stakeholders and commercial decision-makers. |
| Seniority | Manager; Director; VP; C-Level; Owner; Partner; Head | Prioritize decision-makers and budget holders. |
| Job titles | CMO, VP Medical Affairs, Director Clinical Development, Head of Neurology, Clinical Research Director, Medical Science Liaison, Product Manager, Procurement Manager, Digital Health Lead, Operations Director | Focus on the titles most likely to influence adoption, partnership, and purchasing. |
| Geography | South Korea; Seoul Capital Area; Japan; Singapore; China; Taiwan; Australia; United States; Europe | Match the event’s host market and global specialty audience. |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Include hospitals, associations, biotech, pharma, and enterprise vendors. |
| Keywords | Parkinson; movement disorders; neurology; neurodegenerative; clinical trial; biomarker; digital health; neuromodulation; rehabilitation; telemedicine | Refine target lists to event-specific disease and solution themes. |
| Company type | Public company; private company; nonprofit; hospital system; university; government entity | Capture institutional and commercial stakeholders. |
| Revenue range | $10M+ where applicable; prioritize larger healthcare and life sciences firms | Useful for sponsor and enterprise solution targeting. |
Suggested Apollo Search Logic: (neurology OR “movement disorders” OR Parkinson OR neurodegenerative) AND (medical affairs OR clinical development OR research OR procurement OR “digital health” OR “product manager”) AND (Pharmaceuticals OR Biotechnology OR “Hospital & Health Care” OR “Medical Devices” OR Research). Add geography filters for South Korea, APAC, and global pharma hubs.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| International Congress of Parkinson's Disease & Movement Disorders official website | Official organizer / event site | Event name, 2026 dates, Seoul location, venue, organizer, congress purpose, and program themes. | Very High |
| International Parkinson and Movement Disorder Society | Organizer / association | Organizer identity and congress context within the society’s global programming. | Very High |
| COEX Convention and Exhibition Center | Venue website | Venue identity and Seoul convention-center location reference. | High |
| Official 2026 congress program and homepage text | Official event content | Session volume, late-breaking abstract timing, AI caption feature, and collaboration with KMDS. | Very High |
| Official sponsor / exhibit navigation on congress site | Official event content | Confirmed existence of sponsor/exhibit participation options without publishing current participant counts in the supplied text. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Congress of Parkinson's Disease & Movement Disorders — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds